首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.
【24h】

Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.

机译:IL-1受体拮抗剂蛋白的转基因小鼠对疱疹性间质性角膜炎有抵抗力:IL-1在疱疹性间质性角膜炎的发病机理中可能发挥作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Ocular infection with HSV may result in the blinding immunoinflammatory lesion stromal keratitis (SK). This represents a CD4+ T cell-mediated immunopathologic lesion in both humans and a mouse model. Early events in the pathogenesis that set the stage for SK are poorly understood. The present study evaluates the role of IL-1 using a transgenic mouse that overexpresses the IL-1 receptor antagonist (IL-1ra) protein. Such transgenic mice were markedly resistant to SK compared with IL-1ra(-/-) and C57BL/6 control animals. The resistance was shown to be the consequence of reduced expression of molecules such as IL-6, macrophage-inflammatory protein-2, and vascular endothelial growth factor, normally up-regulated directly or indirectly by IL-1. A critical event impaired in IL-1ra transgenic mice was vascular endothelial growth factor production with a consequent marked reduction in angiogenesis, an essential step in SK pathogenesis. Targeting IL-1 could prove to be a worthwhile therapeutic approach to control SK, an important cause of human blindness.
机译:眼部感染HSV可能导致致盲的免疫炎症性病变基质性角膜炎(SK)。这代表了人类和小鼠模型中的CD4 + T细胞介导的免疫病理病变。人们很少了解发病机理中为SK奠定基础的早期事件。本研究使用过表达IL-1受体拮抗剂(IL-1ra)蛋白的转基因小鼠评估IL-1的作用。与IL-1ra(-/-)和C57BL / 6对照动物相比,此类转基因小鼠对SK具有明显的抗性。已显示出这种抗性是通常由IL-1直接或间接上调的诸如IL-6,巨噬细胞炎性蛋白2和血管内皮生长因子之类的分子表达降低的结果。在IL-1ra转基因小鼠中受损的关键事件是血管内皮生长因子的产生,其结果是显着减少了血管生成,这是SK发病机理中必不可少的步骤。靶向IL-1可能是控制SK的一种有价值的治疗方法,SK是人类失明的重要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号